Funding for this research was provided by:
National Institutes of Health (R01CA173023, R35CA232128, P01CA203655, R01CA63113)
Text and Data Mining valid from 2020-03-18
Received: 23 September 2019
Accepted: 27 February 2020
First Online: 18 March 2020
Ethics approval and consent to participate
: This study was conducted according to the Declaration of Helsinki principles and approved by the Dana-Farber Cancer Institute institutional review board (DFCI Protocol No. 18–240). Written informed consent was received from participants prior to inclusion in the study.
: Not applicable.
: JAD has received honoraria for participation in an advisory board with Merck & Co., Inc. JAD has received research funding from Constellation Pharmaceuticals, Inc. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.